TELA Bio, Inc.
TELA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $20,689 | $20,197 | $18,520 | $17,649 |
| % Growth | 2.4% | 9.1% | 4.9% | – |
| Cost of Goods Sold | $6,720 | $6,092 | $6,008 | $6,428 |
| Gross Profit | $13,969 | $14,105 | $12,512 | $11,221 |
| % Margin | 67.5% | 69.8% | 67.6% | 63.6% |
| R&D Expenses | $2,348 | $2,203 | $2,540 | $2,029 |
| G&A Expenses | $3,948 | $4,126 | $3,836 | $3,589 |
| SG&A Expenses | $19,175 | $20,983 | $20,444 | $17,546 |
| Sales & Mktg Exp. | $15,227 | $16,857 | $16,608 | $13,957 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $21,523 | $23,186 | $22,984 | $19,575 |
| Operating Income | -$7,554 | -$9,081 | -$10,472 | -$8,354 |
| % Margin | -36.5% | -45% | -56.5% | -47.3% |
| Other Income/Exp. Net | -$1,049 | -$809 | -$740 | -$998 |
| Pre-Tax Income | -$8,603 | -$9,890 | -$11,212 | -$9,352 |
| Tax Expense | $0 | $33 | $52 | -$144 |
| Net Income | -$8,603 | -$9,923 | -$11,264 | -$9,208 |
| % Margin | -41.6% | -49.1% | -60.8% | -52.2% |
| EPS | -0.19 | -0.22 | -0.25 | -0.23 |
| % Growth | 13.6% | 12% | -8.7% | – |
| EPS Diluted | -0.19 | -0.22 | -0.25 | -0.23 |
| Weighted Avg Shares Out | 45,422 | 45,365 | 45,267 | 40,075 |
| Weighted Avg Shares Out Dil | 45,422 | 45,365 | 45,267 | 40,075 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1,201 | $1,188 | $1,219 | $1,283 |
| Depreciation & Amortization | $248 | $270 | $267 | $266 |
| EBITDA | -$7,154 | -$8,432 | -$9,726 | -$7,803 |
| % Margin | -34.6% | -41.7% | -52.5% | -44.2% |